查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594644

灰指甲治疗市场：按治疗方法、按类型 - 全球预测 2025-2030

Onychomycosis Treatment Market by Treatment (Drugs, Laser Therapy, Photodynamic Therapy), Type (Distal Subungual Onychomycosis, Proximal Subungual Onychomycosis, White Superficial Onychomycosis) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年灰指甲治疗市场估值为19.2亿美元，预计到2024年将达到20.9亿美元，复合年增长率为9.14%，预计到2030年将达到35.4亿美元。

灰指甲治疗市场的范围和定义包括旨在管理和治疗脚趾甲和手指甲真菌感染（通常称为甲癣）的各种治疗策略和产品。对治疗的需求源于与这种疾病相关的严重不适、美容问题和潜在併发症，推动了患者和医疗保健提供者对有效解决方案的需求。治疗方法包括非处方局部药物、处方口服抗真菌药物和使用雷射的新型治疗方法，每种治疗方法都取决于感染的严重程度。最终用途包括私人患者、医疗机构、皮肤科专科诊所等。甲癣盛行率的增加、健康意识的提高、诊断方法的技术进步以及新型治疗製剂的推出对市场成长产生了重大影响。值得注意的机会在于开发更方便、更具成本效益和见效更快的药物，以及意识和获得治疗的机会仍然有限的新兴经济体的开拓中市场。公司可以透过策略性地域多元化、联盟和收购来利用这些机会，以加强产品系列。

主要市场统计
基准年[2023] 19.2亿美元
预测年份 [2024] 20.9亿美元
预测年份 [2030] 35.4亿美元
复合年增长率（%） 9.14%

然而，新药价格高、口服药物潜在副作用、长期治疗方法依从性差以及来自替代疗法和传统疗法的竞争等因素对市场成长构成了挑战。此外，监管障碍和需要大规模临床试验来证明有效性和安全性阻碍了产品的快速开发。需要创新和研究的领域包括改进药物传输系统、提高治疗效果的联合治疗以及开发解决抗真菌抗药性的製剂。由于消费者对更有效、侵入性更小的治疗方法的需求，市场动态正在动态发展。企业应专注于投资研发，利用数位和远端医疗技术，并与研究机构合作，以保持竞争力并推动长期成长。

市场动态：快速发展的灰指甲治疗市场的关键市场洞察

供需的动态交互作用正在改变灰指甲治疗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 提高皮癣菌甲癣治疗产品的标准化
    • 甲癣的高盛行率主要与糖尿病有关
    • 老年人口甲癣病例增加
  • 市场限制因素
    • 替代治疗方案的可用性
  • 市场机会
    • 皮癣菌试纸条检测的研发
    • 增加临床试验以扩大产品系列
  • 市场挑战
    • 药物成功率降低

波特的五力：驾驭灰指甲治疗市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解灰指甲治疗市场的外部影响

外部宏观环境因素在塑造灰指甲治疗市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解灰指甲治疗市场的竞争状况

灰指甲治疗市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵灰指甲治疗市场供应商的绩效评估

FPNV 定位矩阵是评估灰指甲治疗市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了灰指甲治疗市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对灰指甲治疗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 促进甲癣治疗标准化
      • 甲癣的发生率很高，主要与糖尿病有关
      • 老年人甲癣病例增加
    • 抑制因素
      • 替代治疗方案的可用性
    • 机会
      • 皮癣菌检测的发展
      • 增加临床试验以扩大产品系列
    • 任务
      • 药物成功率低
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依治疗方式分類的灰指甲治疗市场

  • 药品
  • 雷射治疗
  • 动态疗法

第七章灰指甲病治疗市场：按类型

  • 远端甲下真菌病
  • 近端甲下真菌病
  • 白色浅层甲癣

第八章北美和南美甲灰指甲治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太灰指甲治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲灰指甲治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Bausch Health Companies Inc.
  • Bayer AG
  • Carise Pharmaceuticals Pvt. Ltd.
  • Cipla Ltd
  • Dr. Reddys Laboratories
  • Galderma SA
  • Galenus Pharma Pvt Ltd
  • Glaxo SmithKline Pharmaceuticals Ltd.
  • Intas Pharmaceuticals Ltd.
  • Johnson & Johnson Services, Inc.
  • Lumenis Ltd. by Boston Scientific Corporation
  • Medimetriks Pharmaceuticals Inc.
  • Moberg Pharma AB
  • Novartis AG
  • Pfizer Inc.
Product Code: MRR-FD3F12D54166

The Onychomycosis Treatment Market was valued at USD 1.92 billion in 2023, expected to reach USD 2.09 billion in 2024, and is projected to grow at a CAGR of 9.14%, to USD 3.54 billion by 2030.

The scope and definition of the onychomycosis treatment market encompass various therapeutic strategies and products designed to manage and cure fungal infections of the toenails and fingernails, a condition commonly known as nail fungus. Necessity for treatment arises from the severe discomfort, cosmetic concerns, and potential complications associated with the disease, driving demand for effective solutions among both patients and healthcare providers. Applications include over-the-counter topical treatments, prescription oral antifungal medications, and newer laser-based therapies, each catering to varying severity of infection. The end-use scope includes individual patients, healthcare facilities, and specialty dermatology clinics. Market growth has been significantly influenced by the increasing prevalence of onychomycosis, greater health awareness, technological advancements in diagnostic methods, and the introduction of novel treatment formulations. Notable opportunities lie in the development of more convenient, cost-effective, and faster-acting medications, and in expanding market presence in emerging economies where awareness and access to treatment remain limited. Companies can capitalize on these opportunities through strategic geographical diversification and partnerships or acquisitions that enhance their product portfolios.

KEY MARKET STATISTICS
Base Year [2023] USD 1.92 billion
Estimated Year [2024] USD 2.09 billion
Forecast Year [2030] USD 3.54 billion
CAGR (%) 9.14%

However, market growth is challenged by factors such as the high cost of newer therapies, potential side effects of oral medications, poor adherence to lengthy treatment regimens, and competition from alternative or traditional remedies. Moreover, regulatory hurdles and the requirement for extensive clinical trials to prove efficacy and safety attributes constrain rapid product development. Areas ripe for innovation and research include the development of improved drug delivery systems, combination therapies that enhance treatment efficacy, and formulations that address antifungal resistance. The nature of the onychomycosis treatment market is dynamically evolving, driven by consumer demand for more efficient and less invasive treatment options. Businesses should focus on investing in R&D, leveraging digital and telemedicine technologies for better patient engagement, and fostering collaborations with research institutions to maintain a competitive edge and drive long-term growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Onychomycosis Treatment Market

The Onychomycosis Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing standardization of dermatophytic onychomycosis therapeutics products
    • High prevalence of dermatophytic onychomycosis, mainly associated with diabetes
    • Increasing the cases of onychomycosis in geriatric population
  • Market Restraints
    • Availability of alternative treatment options
  • Market Opportunities
    • Development of dermatophyte strip tests
    • Rise of clinical trials in order to expand their product portfolio
  • Market Challenges
    • Lower successful ratio of drugs

Porter's Five Forces: A Strategic Tool for Navigating the Onychomycosis Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Onychomycosis Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Onychomycosis Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Onychomycosis Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Onychomycosis Treatment Market

A detailed market share analysis in the Onychomycosis Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Onychomycosis Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Onychomycosis Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Onychomycosis Treatment Market

A strategic analysis of the Onychomycosis Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Onychomycosis Treatment Market, highlighting leading vendors and their innovative profiles. These include Bausch Health Companies Inc., Bayer AG, Carise Pharmaceuticals Pvt. Ltd., Cipla Ltd, Dr. Reddys Laboratories, Galderma S.A., Galenus Pharma Pvt Ltd, Glaxo SmithKline Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Johnson & Johnson Services, Inc., Lumenis Ltd. by Boston Scientific Corporation, Medimetriks Pharmaceuticals Inc., Moberg Pharma AB, Novartis AG, and Pfizer Inc..

Market Segmentation & Coverage

This research report categorizes the Onychomycosis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment, market is studied across Drugs, Laser Therapy, and Photodynamic Therapy.
  • Based on Type, market is studied across Distal Subungual Onychomycosis, Proximal Subungual Onychomycosis, and White Superficial Onychomycosis.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing standardization of dermatophytic onychomycosis therapeutics products
      • 5.1.1.2. High prevalence of dermatophytic onychomycosis, mainly associated with diabetes
      • 5.1.1.3. Increasing the cases of onychomycosis in geriatric population
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of alternative treatment options
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of dermatophyte strip tests
      • 5.1.3.2. Rise of clinical trials in order to expand their product portfolio
    • 5.1.4. Challenges
      • 5.1.4.1. Lower successful ratio of drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Onychomycosis Treatment Market, by Treatment

  • 6.1. Introduction
  • 6.2. Drugs
  • 6.3. Laser Therapy
  • 6.4. Photodynamic Therapy

7. Onychomycosis Treatment Market, by Type

  • 7.1. Introduction
  • 7.2. Distal Subungual Onychomycosis
  • 7.3. Proximal Subungual Onychomycosis
  • 7.4. White Superficial Onychomycosis

8. Americas Onychomycosis Treatment Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Onychomycosis Treatment Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Onychomycosis Treatment Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bausch Health Companies Inc.
  • 2. Bayer AG
  • 3. Carise Pharmaceuticals Pvt. Ltd.
  • 4. Cipla Ltd
  • 5. Dr. Reddys Laboratories
  • 6. Galderma S.A.
  • 7. Galenus Pharma Pvt Ltd
  • 8. Glaxo SmithKline Pharmaceuticals Ltd.
  • 9. Intas Pharmaceuticals Ltd.
  • 10. Johnson & Johnson Services, Inc.
  • 11. Lumenis Ltd. by Boston Scientific Corporation
  • 12. Medimetriks Pharmaceuticals Inc.
  • 13. Moberg Pharma AB
  • 14. Novartis AG
  • 15. Pfizer Inc.

LIST OF FIGURES

  • FIGURE 1. ONYCHOMYCOSIS TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. ONYCHOMYCOSIS TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ONYCHOMYCOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ONYCHOMYCOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ONYCHOMYCOSIS TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ONYCHOMYCOSIS TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY PHOTODYNAMIC THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTAL SUBUNGUAL ONYCHOMYCOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY PROXIMAL SUBUNGUAL ONYCHOMYCOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY WHITE SUPERFICIAL ONYCHOMYCOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ONYCHOMYCOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. ONYCHOMYCOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023